Dare Bioscience Inc (NAS:DARE)
$ 3.2711 -0.1 (-2.98%) Market Cap: 27.96 Mil Enterprise Value: 13.07 Mil PE Ratio: 0.21 PB Ratio: 10.45 GF Score: 34/100

Q3 2020 Dare Bioscience Inc Earnings Call Transcript

Nov 12, 2020 / 09:30PM GMT
Release Date Price: $12.84 (-2.73%)
Operator

Welcome to the conference call hosted by Daré Bioscience to review the company's financial results for the quarter ended September 30, 2020, and to provide a general business update. This call is being recorded. My name is Chris, and I'll be your conference operator today.

With us today are Sabrina Martucci Johnson, Daré's President and Chief Executive Officer; John Fair, Daré's Chief Strategy Officer; and Lisa Walters-Hoffert, Daré's Chief Financial Officer. Miss Johnson, please proceed.

Sabrina Martucci Johnson;Bioscience
DarÃ;Inc. - President, CEO & Director

© -

Thank you. Welcome to our financial results and business update call for Daré Bioscience. We are looking forward to discussing our third quarter results, reflecting on some important achievements to date in 2020, highlighting anticipated developments and milestones for the remainder of 2020 and providing some perspective regarding our plans for 2021. But before I begin, I'd like to remind you that today's discussion will include forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot